HCTI News & Events

Healthcare Triangle announces that its Board of Directors has approved a share repurchase program authorizing the company to repurchase up to $2M of its outstanding common stock. The 2026 Share Repurchase Plan was approved by the company's Board of Directors on March 9, and became effective immediately.

Healthcare Triangle Inc trading halted, volatility trading pause

Healthcare Triangle announced that it has entered into definitive agreements for the purchase and sale of 681,553 shares of common stock at a purchase price of $5.81 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about February 27, subject to the satisfaction of customary closing conditions. D. Boral Capital is acting as sole placement agent for the offering. The gross proceeds to the company from the offering are expected to be approximately $3.959M, before deducting placement agent fees and other offering expenses payable by the company.